Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Edward Nash is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
02/26/2025 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.44 | 525% | Edward Nash66% | $9 → $9 | Maintains | Buy | Get Alert |
02/12/2025 | VRNA | Buy Now | Verona Pharma | $66.65 | 8.03% | Edward Nash66% | $44 → $72 | Maintains | Buy | Get Alert |
02/12/2025 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 113.78% | Edward Nash66% | $22 → $45 | Maintains | Buy | Get Alert |
02/10/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.52 | 163.18% | Edward Nash66% | → $4 | Downgrade | Buy → Hold | Get Alert |
01/30/2025 | CORT | Buy Now | Corcept Therapeutics | $58.32 | 122.91% | Edward Nash66% | $78 → $130 | Maintains | Buy | Get Alert |
01/28/2025 | AKRO | Buy Now | Akero Therapeutics | $45.24 | 61.36% | Edward Nash66% | $56 → $73 | Maintains | Buy | Get Alert |
11/25/2024 | APGE | Buy Now | Apogee Therapeutics | $39.00 | 128.21% | Edward Nash66% | → $89 | Initiates | → Buy | Get Alert |
11/05/2024 | VRNA | Buy Now | Verona Pharma | $66.65 | -33.98% | Edward Nash66% | $37 → $44 | Maintains | Buy | Get Alert |
09/30/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 4.51% | Edward Nash66% | $23 → $22 | Maintains | Buy | Get Alert |
09/10/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 9.26% | Edward Nash66% | $18 → $23 | Maintains | Buy | Get Alert |
08/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 968.7% | Edward Nash66% | $15 → $14 | Maintains | Buy | Get Alert |
07/31/2024 | CORT | Buy Now | Corcept Therapeutics | $58.32 | 33.74% | Edward Nash66% | $38 → $78 | Maintains | Buy | Get Alert |
07/30/2024 | CORT | Buy Now | Corcept Therapeutics | $58.32 | -34.84% | Edward Nash66% | $38 → $38 | Maintains | Buy | Get Alert |
07/22/2024 | VRNA | Buy Now | Verona Pharma | $66.65 | -44.49% | Edward Nash66% | $35 → $37 | Maintains | Buy | Get Alert |
06/27/2024 | VRNA | Buy Now | Verona Pharma | $66.65 | -47.49% | Edward Nash66% | $35 → $35 | Maintains | Buy | Get Alert |
05/23/2024 | CRDL | Buy Now | Cardiol Therapeutics | $1.06 | 654.72% | Edward Nash66% | $6 → $8 | Maintains | Buy | Get Alert |
05/13/2024 | AKRO | Buy Now | Akero Therapeutics | $45.24 | 23.78% | Edward Nash66% | $59 → $56 | Maintains | Buy | Get Alert |
05/07/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | -14.49% | Edward Nash66% | $15 → $18 | Maintains | Buy | Get Alert |
04/08/2024 | IVA | Buy Now | Inventiva | $2.97 | 573.4% | Edward Nash66% | $12 → $20 | Maintains | Buy | Get Alert |
03/27/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.44 | 525% | Edward Nash66% | $21 → $9 | Maintains | Buy | Get Alert |
03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | 9.82% | Edward Nash66% | $338 → $377 | Maintains | Buy | Get Alert |
03/13/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 1045.04% | Edward Nash66% | $16 → $15 | Maintains | Buy | Get Alert |
03/11/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 1121.37% | Edward Nash66% | $20 → $16 | Maintains | Buy | Get Alert |
03/08/2024 | MORF | Buy Now | Morphic Holding | — | — | Edward Nash66% | $68 → $66 | Maintains | Buy | Get Alert |
03/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -1.54% | Edward Nash66% | $336 → $338 | Maintains | Buy | Get Alert |
12/13/2023 | CORT | Buy Now | Corcept Therapeutics | $58.32 | -34.84% | Edward Nash66% | $37 → $38 | Maintains | Buy | Get Alert |
10/27/2023 | IVA | Buy Now | Inventiva | $2.97 | 304.04% | Edward Nash66% | → $12 | Initiates | → Buy | Get Alert |
09/27/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $20 → $19 | Downgrade | Buy → Hold | Get Alert |
09/01/2023 | VRNA | Buy Now | Verona Pharma | $66.65 | -47.49% | Edward Nash66% | → $35 | Reiterates | Buy → Buy | Get Alert |
08/25/2023 | CORT | Buy Now | Corcept Therapeutics | $58.32 | -39.99% | Edward Nash66% | $34 → $35 | Maintains | Buy | Get Alert |
08/03/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $19 → $20 | Maintains | Buy | Get Alert |
07/18/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 66.27% | Edward Nash66% | $37 → $35 | Maintains | Buy | Get Alert |
07/18/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -2.12% | Edward Nash66% | → $336 | Reiterates | Buy → Buy | Get Alert |
07/03/2023 | THTX | Buy Now | Theratechnologies | $2.19 | -8.68% | Edward Nash66% | → $8 | Assumes | → Hold | Get Alert |
06/29/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | — | Upgrade | Hold → Buy | Get Alert |
06/21/2023 | DICE | Buy Now | DICE Therapeutics | — | — | Edward Nash66% | $71 → $48 | Downgrade | Buy → Hold | Get Alert |
06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | Edward Nash66% | $71 → $48 | Downgrade | Buy → Hold | Get Alert |
05/23/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $26 → $12 | Maintains | Hold | Get Alert |
05/22/2023 | DICE | Buy Now | DICE Therapeutics | — | — | Edward Nash66% | → $71 | Initiates | → Buy | Get Alert |
05/19/2023 | RZLT | Buy Now | Rezolute | $2.89 | 488.24% | Edward Nash66% | $16 → $17 | Maintains | Buy | Get Alert |
05/19/2023 | CRDL | Buy Now | Cardiol Therapeutics | $1.06 | 466.04% | Edward Nash66% | $5 → $6 | Maintains | Buy | Get Alert |
05/18/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.52 | 3058.1% | Edward Nash66% | → $48 | Initiates | → Buy | Get Alert |
05/17/2023 | AKRO | Buy Now | Akero Therapeutics | $45.24 | 30.42% | Edward Nash66% | $58 → $59 | Maintains | Buy | Get Alert |
05/17/2023 | ORMP | Buy Now | Oramed Pharmaceuticals | $2.33 | -14.16% | Edward Nash66% | $3 → $2 | Maintains | Hold | Get Alert |
05/10/2023 | VRNA | Buy Now | Verona Pharma | $66.65 | -50.49% | Edward Nash66% | $31 → $33 | Maintains | Below Average | Get Alert |
05/10/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -2.12% | Edward Nash66% | → $336 | Reiterates | → Buy | Get Alert |
03/21/2023 | AKRO | Buy Now | Akero Therapeutics | $45.24 | 28.21% | Edward Nash66% | $50 → $58 | Maintains | Buy | Get Alert |
03/08/2023 | CORT | Buy Now | Corcept Therapeutics | $58.32 | -45.13% | Edward Nash66% | $33 → $32 | Maintains | Buy | Get Alert |
02/28/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -2.12% | Edward Nash66% | $296 → $336 | Maintains | Buy | Get Alert |
02/28/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 99.52% | Edward Nash66% | $44 → $42 | Maintains | Buy | Get Alert |
02/22/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 109.03% | Edward Nash66% | $40 → $44 | Maintains | Buy | Get Alert |
01/31/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 4022.14% | Edward Nash66% | $35 → $54 | Maintains | Buy | Get Alert |
01/30/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 90.02% | Edward Nash66% | $33 → $40 | Maintains | Buy | Get Alert |
01/12/2023 | ORMP | Buy Now | Oramed Pharmaceuticals | $2.33 | — | Edward Nash66% | — | Downgrade | Buy → Hold | Get Alert |
01/10/2023 | AMYT | Buy Now | Amryt Pharma | — | — | Edward Nash66% | $19 → $17 | Downgrade | Buy → Hold | Get Alert |
09/06/2022 | AMYT | Buy Now | Amryt Pharma | — | — | Edward Nash66% | → $19 | Assumes | → Buy | Get Alert |
08/17/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 2571.76% | Edward Nash66% | $30 → $35 | Maintains | Buy | Get Alert |
08/08/2022 | GLMD | Buy Now | Galmed Pharmaceuticals | $1.81 | -44.75% | Edward Nash66% | $900 → $180 | Downgrade | Buy → Hold | Get Alert |
08/05/2022 | CCXI | Buy Now | ChemoCentryx | — | — | Edward Nash66% | → $52 | Downgrade | Buy → Hold | Get Alert |
08/04/2022 | CCXI | Buy Now | ChemoCentryx | — | — | Edward Nash66% | → $81 | Assumes | → Buy | Get Alert |
08/02/2022 | RZLT | Buy Now | Rezolute | $2.89 | 488.24% | Edward Nash66% | → $17 | Assumes | → Buy | Get Alert |
07/14/2022 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 99.52% | Edward Nash66% | → $42 | Assumes | → Buy | Get Alert |
05/10/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $29 → $26 | Maintains | Hold | Get Alert |
04/26/2022 | OBSV | Buy Now | ObsEva | — | — | Edward Nash66% | → $12 | Initiates | → Buy | Get Alert |
03/31/2022 | MORF | Buy Now | Morphic Holding | — | — | Edward Nash66% | → $68 | Initiates | → Buy | Get Alert |
03/31/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.31 | 2190.08% | Edward Nash66% | → $30 | Initiates | → Buy | Get Alert |
03/08/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $31 → $29 | Maintains | Hold | Get Alert |
12/03/2021 | CRDL | Buy Now | Cardiol Therapeutics | $1.06 | 654.72% | Edward Nash66% | → $8 | Initiates | → Buy | Get Alert |
11/12/2021 | VRNA | Buy Now | Verona Pharma | $66.65 | -65.49% | Edward Nash66% | $18 → $23 | Maintains | Buy | Get Alert |
10/22/2021 | MTCR | Buy Now | Metacrine | — | — | Edward Nash66% | $19 → $1 | Downgrade | Buy → Hold | Get Alert |
08/03/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $43 → $31 | Maintains | Hold | Get Alert |
07/29/2021 | ORMP | Buy Now | Oramed Pharmaceuticals | $2.33 | 1187.55% | Edward Nash66% | $27 → $30 | Maintains | Buy | Get Alert |
07/29/2021 | THTX | Buy Now | Theratechnologies | $2.19 | 36.99% | Edward Nash66% | $32 → $12 | Downgrade | Buy → Hold | Get Alert |
05/17/2021 | GLMD | Buy Now | Galmed Pharmaceuticals | $1.81 | 1060.22% | Edward Nash66% | $3600 → $3780 | Maintains | Buy | Get Alert |
05/17/2021 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -43.78% | Edward Nash66% | $179 → $193 | Maintains | Buy | Get Alert |
05/03/2021 | VRNA | Buy Now | Verona Pharma | $66.65 | -72.99% | Edward Nash66% | $19 → $18 | Maintains | Buy | Get Alert |
04/20/2021 | ORMP | Buy Now | Oramed Pharmaceuticals | $2.33 | 1058.8% | Edward Nash66% | → $27 | Initiates | → Buy | Get Alert |
04/19/2021 | THTX | Buy Now | Theratechnologies | $2.19 | 265.3% | Edward Nash66% | $28 → $32 | Maintains | Buy | Get Alert |
03/18/2021 | AKRO | Buy Now | Akero Therapeutics | $45.24 | 1.68% | Edward Nash66% | $51 → $46 | Maintains | Buy | Get Alert |
11/12/2020 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -48.44% | Edward Nash66% | $198 → $177 | Maintains | Buy | Get Alert |
11/11/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | $42 → $58 | Maintains | Hold | Get Alert |
10/12/2020 | MTCR | Buy Now | Metacrine | — | — | Edward Nash66% | → $19 | Initiates | → Buy | Get Alert |
08/10/2020 | VRNA | Buy Now | Verona Pharma | $66.65 | -74.49% | Edward Nash66% | → $17 | Initiates | → Buy | Get Alert |
06/29/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Edward Nash66% | → $58 | Downgrade | Buy → Hold | Get Alert |
06/19/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | 111.94% | Edward Nash66% | $80 → $82 | Maintains | Buy | Get Alert |
04/15/2020 | THTX | Buy Now | Theratechnologies | $2.19 | 402.28% | Edward Nash66% | $48 → $44 | Maintains | Buy | Get Alert |
02/10/2020 | AKRO | Buy Now | Akero Therapeutics | $45.24 | -20.42% | Edward Nash66% | → $36 | Initiates | → Buy | Get Alert |
01/30/2020 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | -42.32% | Edward Nash66% | → $198 | Initiates | → Buy | Get Alert |
01/10/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | 106.77% | Edward Nash66% | $75 → $80 | Maintains | Buy | Get Alert |
09/13/2019 | ADVM | Buy Now | Adverum Biotechnologies | $4.93 | 62.27% | Edward Nash66% | $120 → $80 | Maintains | Hold | Get Alert |
11/13/2018 | AKAO | Buy Now | Achaogen | — | — | Edward Nash66% | $10 → $3 | Downgrade | Buy → Hold | Get Alert |
11/02/2018 | ADVM | Buy Now | Adverum Biotechnologies | $4.93 | — | Edward Nash66% | — | Downgrade | Buy → Hold | Get Alert |
10/29/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | 39.57% | Edward Nash66% | $83 → $54 | Maintains | Buy | Get Alert |
10/24/2018 | ETTX | Buy Now | Entasis Therapeutics Hldg | — | — | Edward Nash66% | → $20 | Initiates | → Buy | Get Alert |
08/30/2018 | ADVM | Buy Now | Adverum Biotechnologies | $4.93 | 123.12% | Edward Nash66% | → $110 | Initiates | → Buy | Get Alert |
05/24/2018 | QURE | Buy Now | uniQure | $14.36 | 234.26% | Edward Nash66% | → $48 | Initiates | → Buy | Get Alert |
04/18/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | — | Edward Nash66% | — | Upgrade | Hold → Buy | Get Alert |
11/08/2017 | ABEO | Buy Now | Abeona Therapeutics | $5.00 | 420% | Edward Nash66% | → $650 | Initiates | → Buy | Get Alert |
09/22/2017 | VSAR | Buy Now | Versartis | — | — | Edward Nash66% | — | Downgrade | Buy → Hold | Get Alert |
08/23/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | 42.16% | Edward Nash66% | → $55 | Downgrade | Buy → Hold | Get Alert |
12/01/2016 | VSAR | Buy Now | Versartis | — | — | Edward Nash66% | → $150 | Initiates | → Buy | Get Alert |
04/14/2015 | VSAR | Buy Now | Versartis | — | — | Edward Nash66% | → $300 | Initiates | → Buy | Get Alert |
11/04/2014 | AKAO | Buy Now | Achaogen | — | — | Edward Nash66% | → $22 | Initiates | → Buy | Get Alert |
10/16/2014 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.69 | 111.94% | Edward Nash66% | → $82 | Initiates | → Buy | Get Alert |